MediciNova Inc. (MNOV): A Detailed Report for Recent Quarter of MNOV

B. Riley FBR announced it was Resumed coverage of MediciNova Inc. in a research note on March 25, 2019. The analysts assigned a Buy rating to the stock. B. Riley FBR Inc. rated the stock as a Buy in a research noted published on March 28, 2018. Credit Suisse rated the stock as an Outperform in a research note published on April 18, 2017.

Matsuda Kazuko, the Chief Medical Officer of MediciNova Inc., bought 2000.0 shares at the valuation of $3.62 during an exchange that occurred on Mar 13, which implies that Matsuda Kazuko is holding 111,476 shares at the estimation of $7,240 dependent on the most recent closing price.

In another transaction, on Mar 12, President and CEO of MediciNova Inc., IWAKI YUICHI, bought 20000.0 shares at the price of $3.10. After this activity, IWAKI YUICHI now keeps 780,683 shares of MediciNova Inc., esteemed at $62,000 with the most recent shutting price.

MNOV Recent Trade

The share price of MNOV ascended by $5.36 during the exchanging session on 07/27/20 to exchange at $11.00. MediciNova Inc. stock has an exchanging volume of 82.45 million shares, which is high, contrasted with its 3-months average volume of 1.43M shares. Its market capitalization has now reached to $495.00M.

MNOV Past Trading Activity

The market tends to become urbane often, in any event, for prepared investors and traders. In any event, when a merchant got what he/she had expected, the market occasionally chooses to move the other way. This instability leads a few traders questioning and re-thinking their moves. This is the reason becoming acquainted with past price performance, just as both long and short time period, is significant. If we look the past performance, during the last one week, MNOV price has rose by 87.39%. In the course of past three months sees the stock go up around 98.56%, while it has gain 80.33% over the past six months and 63.20% since the start of the year.

MNOV Earning History

Earnings per share are the amount of profit that a company produces during a specific period, which is usually defined as a quarter (three calendar months) or a year. In recent quarter of (Jun 2020), MediciNova Inc. posted -$0.06 earnings per share (EPS) which was above the consensus estimate of -$0.08 by $0.02, which represents to an expansion by 25.00%.

MNOV Price Performance

Let us presently take a gander at a portion of its probable help and opposition resistance. Late research on MediciNova Inc. has seen its stock exchanging -16.98% underneath its three-month high price. A glance at the opposite side additionally observes stock exchanging +123.12% above its three-month low. A more extensive look sees MNOV exchanging 12.00% beneath its 52-week high and 294.27% above from its 52-week low price.

MNOV Instability & Beta Factor

The Volatility of a stock means that the stock’s drop or increase in the event that the more extensive market drops or rushes. A beta score higher than 1 implies that a stock is profoundly unpredictable while underneath 1 implies that the Volatility of a stock is low. If we look trading Volatility. Its 7-day Volatility is around 23.96%, while it has a month to month instability of 9.75%. The firm has an ATR (Average True Range) of 0.79 and a beta factor of 1.72.

Leave a Comment